<?xml version='1.0' encoding='utf-8'?>
<document id="29575226"><sentence text="Discontinuation and dose adjustment of metoprolol after metoprolol-paroxetine/fluoxetine co-prescription in Dutch elderly."><entity charOffset="39-49" id="DDI-PubMed.29575226.s1.e0" text="metoprolol" /><entity charOffset="56-66" id="DDI-PubMed.29575226.s1.e1" text="metoprolol" /><entity charOffset="67-77" id="DDI-PubMed.29575226.s1.e2" text="paroxetine" /><entity charOffset="78-88" id="DDI-PubMed.29575226.s1.e3" text="fluoxetine" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e0" e2="DDI-PubMed.29575226.s1.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e0" e2="DDI-PubMed.29575226.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e0" e2="DDI-PubMed.29575226.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e0" e2="DDI-PubMed.29575226.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e1" e2="DDI-PubMed.29575226.s1.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e1" e2="DDI-PubMed.29575226.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e1" e2="DDI-PubMed.29575226.s1.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e2" e2="DDI-PubMed.29575226.s1.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s1.e2" e2="DDI-PubMed.29575226.s1.e3" /></sentence><sentence text="Co-prescription of paroxetine/fluoxetine (a strong CYP2D6 inhibitor) in metoprolol (a CYP2D6 substrate) users is common, but data on the clinical consequences of this drug-drug interaction are limited and inconclusive"><entity charOffset="19-29" id="DDI-PubMed.29575226.s2.e0" text="paroxetine" /><entity charOffset="30-40" id="DDI-PubMed.29575226.s2.e1" text="fluoxetine" /><entity charOffset="72-82" id="DDI-PubMed.29575226.s2.e2" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.29575226.s2.e0" e2="DDI-PubMed.29575226.s2.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s2.e0" e2="DDI-PubMed.29575226.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s2.e0" e2="DDI-PubMed.29575226.s2.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s2.e1" e2="DDI-PubMed.29575226.s2.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s2.e1" e2="DDI-PubMed.29575226.s2.e2" /></sentence><sentence text=" Therefore, we assessed the effect of paroxetine/fluoxetine initiation on the existing treatment with metoprolol on the discontinuation and dose adjustment of metoprolol among elderly"><entity charOffset="38-48" id="DDI-PubMed.29575226.s3.e0" text="paroxetine" /><entity charOffset="49-59" id="DDI-PubMed.29575226.s3.e1" text="fluoxetine" /><entity charOffset="102-112" id="DDI-PubMed.29575226.s3.e2" text="metoprolol" /><entity charOffset="159-169" id="DDI-PubMed.29575226.s3.e3" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e0" e2="DDI-PubMed.29575226.s3.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e0" e2="DDI-PubMed.29575226.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e0" e2="DDI-PubMed.29575226.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e0" e2="DDI-PubMed.29575226.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e1" e2="DDI-PubMed.29575226.s3.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e1" e2="DDI-PubMed.29575226.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e1" e2="DDI-PubMed.29575226.s3.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e2" e2="DDI-PubMed.29575226.s3.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s3.e2" e2="DDI-PubMed.29575226.s3.e3" /></sentence><sentence text="" /><sentence text="We performed a cohort study using the University of Groningen IADB" /><sentence text="nl prescription database (www" /><sentence text="IADB" /><sentence text="nl)" /><sentence text=" We selected all elderly (≥60 years) who had ever been prescribed metoprolol and had a first co-prescription of paroxetine/fluoxetine, citalopram (weak CYP2D6 inhibitor), or mirtazapine (negative control) from 1994 to 2015"><entity charOffset="66-76" id="DDI-PubMed.29575226.s9.e0" text="metoprolol" /><entity charOffset="112-122" id="DDI-PubMed.29575226.s9.e1" text="paroxetine" /><entity charOffset="123-133" id="DDI-PubMed.29575226.s9.e2" text="fluoxetine" /><entity charOffset="135-145" id="DDI-PubMed.29575226.s9.e3" text="citalopram" /><entity charOffset="174-185" id="DDI-PubMed.29575226.s9.e4" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e0" e2="DDI-PubMed.29575226.s9.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e0" e2="DDI-PubMed.29575226.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e0" e2="DDI-PubMed.29575226.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e0" e2="DDI-PubMed.29575226.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e0" e2="DDI-PubMed.29575226.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e1" e2="DDI-PubMed.29575226.s9.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e1" e2="DDI-PubMed.29575226.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e1" e2="DDI-PubMed.29575226.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e1" e2="DDI-PubMed.29575226.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e2" e2="DDI-PubMed.29575226.s9.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e2" e2="DDI-PubMed.29575226.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e2" e2="DDI-PubMed.29575226.s9.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e3" e2="DDI-PubMed.29575226.s9.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s9.e3" e2="DDI-PubMed.29575226.s9.e4" /></sentence><sentence text=" The exposure group was metoprolol and paroxetine/fluoxetine co-prescription, and the other groups acted as controls"><entity charOffset="24-34" id="DDI-PubMed.29575226.s10.e0" text="metoprolol" /><entity charOffset="39-49" id="DDI-PubMed.29575226.s10.e1" text="paroxetine" /><entity charOffset="50-60" id="DDI-PubMed.29575226.s10.e2" text="fluoxetine" /><pair ddi="false" e1="DDI-PubMed.29575226.s10.e0" e2="DDI-PubMed.29575226.s10.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s10.e0" e2="DDI-PubMed.29575226.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s10.e0" e2="DDI-PubMed.29575226.s10.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s10.e1" e2="DDI-PubMed.29575226.s10.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s10.e1" e2="DDI-PubMed.29575226.s10.e2" /></sentence><sentence text=" The outcomes were early discontinuation and dose adjustment of metoprolol"><entity charOffset="64-74" id="DDI-PubMed.29575226.s11.e0" text="metoprolol" /></sentence><sentence text=" Logistic regression was applied to estimate adjusted odds ratios (OR) and 95% confidence intervals (CI)" /><sentence text="" /><sentence text="Combinations of metoprolol-paroxetine/fluoxetine, metoprolol-citalopram, and metoprolol-mirtazapine were started in 528, 673, and 625 patients, respectively"><entity charOffset="16-26" id="DDI-PubMed.29575226.s14.e0" text="metoprolol" /><entity charOffset="27-37" id="DDI-PubMed.29575226.s14.e1" text="paroxetine" /><entity charOffset="38-48" id="DDI-PubMed.29575226.s14.e2" text="fluoxetine" /><entity charOffset="50-60" id="DDI-PubMed.29575226.s14.e3" text="metoprolol" /><entity charOffset="61-71" id="DDI-PubMed.29575226.s14.e4" text="citalopram" /><entity charOffset="77-87" id="DDI-PubMed.29575226.s14.e5" text="metoprolol" /><entity charOffset="88-99" id="DDI-PubMed.29575226.s14.e6" text="mirtazapine" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e0" e2="DDI-PubMed.29575226.s14.e6" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e1" e2="DDI-PubMed.29575226.s14.e6" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e2" e2="DDI-PubMed.29575226.s14.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e2" e2="DDI-PubMed.29575226.s14.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e2" e2="DDI-PubMed.29575226.s14.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e2" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e2" e2="DDI-PubMed.29575226.s14.e6" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e3" e2="DDI-PubMed.29575226.s14.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e3" e2="DDI-PubMed.29575226.s14.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e3" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e3" e2="DDI-PubMed.29575226.s14.e6" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e4" e2="DDI-PubMed.29575226.s14.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e4" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e4" e2="DDI-PubMed.29575226.s14.e6" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e5" e2="DDI-PubMed.29575226.s14.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s14.e5" e2="DDI-PubMed.29575226.s14.e6" /></sentence><sentence text=" Compared with metoprolol-citalopram, metoprolol-paroxetine/fluoxetine was not significantly associated with the early discontinuation and dose adjustment of metoprolol (OR = 1"><entity charOffset="38-48" id="DDI-PubMed.29575226.s15.e0" text="metoprolol" /><entity charOffset="49-59" id="DDI-PubMed.29575226.s15.e1" text="paroxetine" /><entity charOffset="60-70" id="DDI-PubMed.29575226.s15.e2" text="fluoxetine" /><entity charOffset="158-168" id="DDI-PubMed.29575226.s15.e3" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e0" e2="DDI-PubMed.29575226.s15.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e0" e2="DDI-PubMed.29575226.s15.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e0" e2="DDI-PubMed.29575226.s15.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e0" e2="DDI-PubMed.29575226.s15.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e1" e2="DDI-PubMed.29575226.s15.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e1" e2="DDI-PubMed.29575226.s15.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e1" e2="DDI-PubMed.29575226.s15.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e2" e2="DDI-PubMed.29575226.s15.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s15.e2" e2="DDI-PubMed.29575226.s15.e3" /></sentence><sentence text="07, 95% CI:0" /><sentence text="77-1" /><sentence text="48; OR = 0" /><sentence text="87, 95% CI:0" /><sentence text="57-1" /><sentence text="33, respectively)" /><sentence text=" In comparison with metoprolol-mirtazapine, metoprolol-paroxetine/fluoxetine was associated with a significant 43% relative increase in early discontinuation of metoprolol (OR = 1"><entity charOffset="20-30" id="DDI-PubMed.29575226.s22.e0" text="metoprolol" /><entity charOffset="31-42" id="DDI-PubMed.29575226.s22.e1" text="mirtazapine" /><entity charOffset="44-54" id="DDI-PubMed.29575226.s22.e2" text="metoprolol" /><entity charOffset="55-65" id="DDI-PubMed.29575226.s22.e3" text="paroxetine" /><entity charOffset="66-76" id="DDI-PubMed.29575226.s22.e4" text="fluoxetine" /><entity charOffset="161-171" id="DDI-PubMed.29575226.s22.e5" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e0" e2="DDI-PubMed.29575226.s22.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e1" e2="DDI-PubMed.29575226.s22.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e1" e2="DDI-PubMed.29575226.s22.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e1" e2="DDI-PubMed.29575226.s22.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e1" e2="DDI-PubMed.29575226.s22.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e1" e2="DDI-PubMed.29575226.s22.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e2" e2="DDI-PubMed.29575226.s22.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e2" e2="DDI-PubMed.29575226.s22.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e2" e2="DDI-PubMed.29575226.s22.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e2" e2="DDI-PubMed.29575226.s22.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e3" e2="DDI-PubMed.29575226.s22.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e3" e2="DDI-PubMed.29575226.s22.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e3" e2="DDI-PubMed.29575226.s22.e5" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e4" e2="DDI-PubMed.29575226.s22.e4" /><pair ddi="false" e1="DDI-PubMed.29575226.s22.e4" e2="DDI-PubMed.29575226.s22.e5" /></sentence><sentence text="43, 95% CI:1" /><sentence text="01-2" /><sentence text="02) but no difference in the risk of dose adjustment" /><sentence text=" Stratified analysis by gender showed that women have a significantly high risk of metoprolol early discontinuation (OR = 1"><entity charOffset="83-93" id="DDI-PubMed.29575226.s26.e0" text="metoprolol" /></sentence><sentence text="62, 95% CI:1" /><sentence text="03-2" /><sentence text="53)" /><sentence text="" /><sentence text="Paroxetine/fluoxetine initiation in metoprolol prescriptions, especially for female older patients, is associated with the risk of early discontinuation of metoprolol"><entity charOffset="0-10" id="DDI-PubMed.29575226.s31.e0" text="Paroxetine" /><entity charOffset="11-21" id="DDI-PubMed.29575226.s31.e1" text="fluoxetine" /><entity charOffset="36-46" id="DDI-PubMed.29575226.s31.e2" text="metoprolol" /><entity charOffset="156-166" id="DDI-PubMed.29575226.s31.e3" text="metoprolol" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e0" e2="DDI-PubMed.29575226.s31.e0" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e0" e2="DDI-PubMed.29575226.s31.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e0" e2="DDI-PubMed.29575226.s31.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e0" e2="DDI-PubMed.29575226.s31.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e1" e2="DDI-PubMed.29575226.s31.e1" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e1" e2="DDI-PubMed.29575226.s31.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e1" e2="DDI-PubMed.29575226.s31.e3" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e2" e2="DDI-PubMed.29575226.s31.e2" /><pair ddi="false" e1="DDI-PubMed.29575226.s31.e2" e2="DDI-PubMed.29575226.s31.e3" /></sentence><sentence text="" /></document>